Statement of America’s Blood Centers to the United States International Trade Commission

On September 23, 2020, Kate Fry, CEO at America’s Blood Centers, provided testimony before the U.S. International Trade Commission on the role of independent blood centers during the COVID-19 pandemic. Key highlights include the critical role and experience of community blood centers during the COVID-19 pandemic, including the collection of COVID-19 Convalescent Plasma, shifting operations to maintain a robust blood supply, and supply chain challenges.